By Eleanor Garth – Longevity.Technology –
PET tracer derived from an ALS treatment provides a method to quantify damage from oxidative stress in the brain.
A newly developed positron emission tomography (PET) imaging probe, derived from the drug edaravone, has demonstrated potential for detecting oxidative stress in the central nervous system – an underlying factor in neurodegenerative diseases such as Alzheimer’s and amyotrophic lateral sclerosis (ALS).
